Debu Tripathy, Md, On Immunotherapies Being Studied For Treatment Of Metastatic Breast Cancer

Debu Tripathy, MD, on immunotherapies being studied for treatment of metastatic breast cancer

Dr. Debu Tripathy on Further Investigation Into Immunotherapies in Breast Cancer

Targeted Oncology

Dr. Tripathy on the Treatment of Patients With Metastatic Breast Cancer

Debu Tripathy, MD, elaborates on the SOPHIA trial in HER+ metastatic breast cancer

Debu Tripathy, MD, on presentations pertaining to immunotherapy in early breast cancer treatment

Dr. Debu Tripathy Gives an Overview of Targeted Therapies for Breast Cancer

Debu Tripathy, MD, on how the APHINITY study could impact treatment of adjuvant breast cancer

SABCS: Debu Tripathy Discusses Immunotherapy in Breast Cancer

Debu Tripathy on Hormone Therapy Compliance in Patients with Breast Cancer

Debu Tripathy on Hormonal Therapy for Breast Cancer

NCI Minute: Immunotherapy for Metastatic Breast Cancer

National Cancer Institute

Debu Tripathy on Using Breast Cancer Tumor DNA to Make Treatment Decisions

Dr. Tripathy Discusses Immunotherapy in HER2+ Breast Cancer

Debu Tripathy, MD explains how liquid biopsy figures into breast cancer treatment

Debu Tripathy, MD, discusses recent FDA approvals and HER2+ metastatic breast cancer management

Debu Tripathy, MD, elaborates on outcomes from the ImPassion130 trial

Dr. Tripathy on Bisphosphonates in Breast Cancer

Dr. Tripathy on the Possibility of Curing Metastatic Breast Cancer

Debu Tripathy, MD provides update on breast cancer treatment algorithms impacted by PD-L1

Dr. Tripathy on Immunotherapy Potential in HER2-Positive Breast Cancer